Global Donor Transfusion Diagnosis Supply, Demand and Key Producers, 2026-2032
The global Donor Transfusion Diagnosis market size is expected to reach $ 4249 million by 2032, rising at a market growth of 8.7% CAGR during the forecast period (2026-2032).
The gross profit margin of major companies in the industry is between 40%?60%.
Donor Transfusion Diagnosis refers to laboratory diagnostic testing performed to evaluate blood donors and ensure compatibility and safety in blood transfusion procedures. These tests are designed to detect infectious diseases, determine blood group compatibility, and screen for antibodies that may affect transfusion outcomes. Diagnostic methods typically include immunohematology testing, nucleic acid testing, and serological assays. These diagnostic procedures are critical for ensuring safe blood supply in hospitals and blood banks, preventing transfusion reactions, and reducing the risk of disease transmission through donated blood.
The industrial chain includes upstream diagnostic reagents, laboratory instruments, blood testing kits, and sample collection materials. Midstream processes involve laboratory testing, blood typing analysis, infection screening, and clinical validation. Downstream users include blood banks, hospitals, clinical laboratories, and healthcare systems responsible for blood transfusion management. Supporting services include laboratory quality control, data management systems, and regulatory compliance programs.
The donor transfusion diagnosis market is expanding due to increasing global demand for safe blood transfusion and improved healthcare systems. Rising awareness of blood safety and the need for accurate screening of infectious diseases are driving the adoption of advanced diagnostic technologies. Technological developments in nucleic acid testing and automated laboratory systems are improving detection sensitivity and testing efficiency. Healthcare institutions are investing in modern diagnostic platforms to ensure reliable blood compatibility testing and regulatory compliance. However, regulatory requirements and the cost of advanced diagnostic technologies may influence market adoption in certain regions. Overall, the growing demand for blood transfusion services and improved diagnostic capabilities is expected to support steady growth in the donor transfusion diagnosis market.
This report studies the global Donor Transfusion Diagnosis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Donor Transfusion Diagnosis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Donor Transfusion Diagnosis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Donor Transfusion Diagnosis total market, 2021-2032, (USD Million)
Global Donor Transfusion Diagnosis total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Donor Transfusion Diagnosis total market, key domestic companies, and share, (USD Million)
Global Donor Transfusion Diagnosis revenue by player, revenue and market share 2021-2026, (USD Million)
Global Donor Transfusion Diagnosis total market by Type, CAGR, 2021-2032, (USD Million)
Global Donor Transfusion Diagnosis total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Donor Transfusion Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH, Diasorin, Prestige Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Donor Transfusion Diagnosis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Donor Transfusion Diagnosis Market, By Region:
1. How big is the global Donor Transfusion Diagnosis market?
2. What is the demand of the global Donor Transfusion Diagnosis market?
3. What is the year over year growth of the global Donor Transfusion Diagnosis market?
4. What is the total value of the global Donor Transfusion Diagnosis market?
5. Who are the Major Players in the global Donor Transfusion Diagnosis market?
6. What are the growth factors driving the market demand?
The gross profit margin of major companies in the industry is between 40%?60%.
Donor Transfusion Diagnosis refers to laboratory diagnostic testing performed to evaluate blood donors and ensure compatibility and safety in blood transfusion procedures. These tests are designed to detect infectious diseases, determine blood group compatibility, and screen for antibodies that may affect transfusion outcomes. Diagnostic methods typically include immunohematology testing, nucleic acid testing, and serological assays. These diagnostic procedures are critical for ensuring safe blood supply in hospitals and blood banks, preventing transfusion reactions, and reducing the risk of disease transmission through donated blood.
The industrial chain includes upstream diagnostic reagents, laboratory instruments, blood testing kits, and sample collection materials. Midstream processes involve laboratory testing, blood typing analysis, infection screening, and clinical validation. Downstream users include blood banks, hospitals, clinical laboratories, and healthcare systems responsible for blood transfusion management. Supporting services include laboratory quality control, data management systems, and regulatory compliance programs.
The donor transfusion diagnosis market is expanding due to increasing global demand for safe blood transfusion and improved healthcare systems. Rising awareness of blood safety and the need for accurate screening of infectious diseases are driving the adoption of advanced diagnostic technologies. Technological developments in nucleic acid testing and automated laboratory systems are improving detection sensitivity and testing efficiency. Healthcare institutions are investing in modern diagnostic platforms to ensure reliable blood compatibility testing and regulatory compliance. However, regulatory requirements and the cost of advanced diagnostic technologies may influence market adoption in certain regions. Overall, the growing demand for blood transfusion services and improved diagnostic capabilities is expected to support steady growth in the donor transfusion diagnosis market.
This report studies the global Donor Transfusion Diagnosis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Donor Transfusion Diagnosis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Donor Transfusion Diagnosis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Donor Transfusion Diagnosis total market, 2021-2032, (USD Million)
Global Donor Transfusion Diagnosis total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Donor Transfusion Diagnosis total market, key domestic companies, and share, (USD Million)
Global Donor Transfusion Diagnosis revenue by player, revenue and market share 2021-2026, (USD Million)
Global Donor Transfusion Diagnosis total market by Type, CAGR, 2021-2032, (USD Million)
Global Donor Transfusion Diagnosis total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Donor Transfusion Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, F. Hoffmann-La Roche, Abbott, Bio-Rad Laboratories, Werfen, QuidelOrtho Corporation, AliveDx Holdings Finance, BAG Diagnostics GmbH, Diasorin, Prestige Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Donor Transfusion Diagnosis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Donor Transfusion Diagnosis Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Instruments
- Kits and Reagents
- Blood Type Identification
- Infectious Disease Screening
- Antibody Screening
- Automated Blood Testing System
- Manual Diagnostic Kit
- Integrated Blood Analysis System
- Blood Banks
- Blood Donation/Transfusion Centers
- Others
- Grifols
- F. Hoffmann-La Roche
- Abbott
- Bio-Rad Laboratories
- Werfen
- QuidelOrtho Corporation
- AliveDx Holdings Finance
- BAG Diagnostics GmbH
- Diasorin
- Prestige Diagnostics
- Atlas Medical GmbH
- Lorne Laboratories
1. How big is the global Donor Transfusion Diagnosis market?
2. What is the demand of the global Donor Transfusion Diagnosis market?
3. What is the year over year growth of the global Donor Transfusion Diagnosis market?
4. What is the total value of the global Donor Transfusion Diagnosis market?
5. Who are the Major Players in the global Donor Transfusion Diagnosis market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Donor Transfusion Diagnosis Introduction
1.2 World Donor Transfusion Diagnosis Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Donor Transfusion Diagnosis Total Market by Region (by Headquarter Location)
1.3.1 World Donor Transfusion Diagnosis Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.3 China Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.4 Europe Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.5 Japan Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.6 South Korea Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.7 ASEAN Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.8 India Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Donor Transfusion Diagnosis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.2 World Donor Transfusion Diagnosis Consumption Value by Region
2.2.1 World Donor Transfusion Diagnosis Consumption Value by Region (2021-2026)
2.2.2 World Donor Transfusion Diagnosis Consumption Value Forecast by Region (2027-2032)
2.3 United States Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.4 China Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.5 Europe Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.6 Japan Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.7 South Korea Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.8 ASEAN Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.9 India Donor Transfusion Diagnosis Consumption Value (2021-2032)
3 WORLD DONOR TRANSFUSION DIAGNOSIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Donor Transfusion Diagnosis Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Donor Transfusion Diagnosis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Donor Transfusion Diagnosis in 2025
3.2.3 Global Concentration Ratios (CR8) for Donor Transfusion Diagnosis in 2025
3.3 Donor Transfusion Diagnosis Company Evaluation Quadrant
3.4 Donor Transfusion Diagnosis Market: Overall Company Footprint Analysis
3.4.1 Donor Transfusion Diagnosis Market: Region Footprint
3.4.2 Donor Transfusion Diagnosis Market: Company Product Type Footprint
3.4.3 Donor Transfusion Diagnosis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Donor Transfusion Diagnosis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Donor Transfusion Diagnosis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Donor Transfusion Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Donor Transfusion Diagnosis Consumption Value Comparison
4.2.1 United States VS China: Donor Transfusion Diagnosis Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Donor Transfusion Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Donor Transfusion Diagnosis Companies and Market Share, 2021-2026
4.3.1 United States Based Donor Transfusion Diagnosis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Donor Transfusion Diagnosis Revenue, (2021-2026)
4.4 China Based Companies Donor Transfusion Diagnosis Revenue and Market Share, 2021-2026
4.4.1 China Based Donor Transfusion Diagnosis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Donor Transfusion Diagnosis Revenue, (2021-2026)
4.5 Rest of World Based Donor Transfusion Diagnosis Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Donor Transfusion Diagnosis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Donor Transfusion Diagnosis Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Donor Transfusion Diagnosis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Instruments
5.2.2 Kits and Reagents
5.3 Market Segment by Type
5.3.1 World Donor Transfusion Diagnosis Market Size by Type (2021-2026)
5.3.2 World Donor Transfusion Diagnosis Market Size by Type (2027-2032)
5.3.3 World Donor Transfusion Diagnosis Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TEST TARGET
6.1 World Donor Transfusion Diagnosis Market Size Overview by Test Target: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Test Target
6.2.1 Blood Type Identification
6.2.2 Infectious Disease Screening
6.2.3 Antibody Screening
6.3 Market Segment by Test Target
6.3.1 World Donor Transfusion Diagnosis Market Size by Test Target (2021-2026)
6.3.2 World Donor Transfusion Diagnosis Market Size by Test Target (2027-2032)
6.3.3 World Donor Transfusion Diagnosis Market Size Market Share by Test Target (2027-2032)
7 MARKET ANALYSIS BY EQUIPMENT TYPE
7.1 World Donor Transfusion Diagnosis Market Size Overview by Equipment Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Equipment Type
7.2.1 Automated Blood Testing System
7.2.2 Manual Diagnostic Kit
7.2.3 Integrated Blood Analysis System
7.3 Market Segment by Equipment Type
7.3.1 World Donor Transfusion Diagnosis Market Size by Equipment Type (2021-2026)
7.3.2 World Donor Transfusion Diagnosis Market Size by Equipment Type (2027-2032)
7.3.3 World Donor Transfusion Diagnosis Market Size Market Share by Equipment Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Donor Transfusion Diagnosis Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Blood Banks
8.2.2 Blood Donation/Transfusion Centers
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Donor Transfusion Diagnosis Market Size by Application (2021-2026)
8.3.2 World Donor Transfusion Diagnosis Market Size by Application (2027-2032)
8.3.3 World Donor Transfusion Diagnosis Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Grifols
9.1.1 Grifols Details
9.1.2 Grifols Major Business
9.1.3 Grifols Donor Transfusion Diagnosis Product and Services
9.1.4 Grifols Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Grifols Recent Developments/Updates
9.1.6 Grifols Competitive Strengths & Weaknesses
9.2 F. Hoffmann-La Roche
9.2.1 F. Hoffmann-La Roche Details
9.2.2 F. Hoffmann-La Roche Major Business
9.2.3 F. Hoffmann-La Roche Donor Transfusion Diagnosis Product and Services
9.2.4 F. Hoffmann-La Roche Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 F. Hoffmann-La Roche Recent Developments/Updates
9.2.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
9.3 Abbott
9.3.1 Abbott Details
9.3.2 Abbott Major Business
9.3.3 Abbott Donor Transfusion Diagnosis Product and Services
9.3.4 Abbott Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Abbott Recent Developments/Updates
9.3.6 Abbott Competitive Strengths & Weaknesses
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Details
9.4.2 Bio-Rad Laboratories Major Business
9.4.3 Bio-Rad Laboratories Donor Transfusion Diagnosis Product and Services
9.4.4 Bio-Rad Laboratories Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Bio-Rad Laboratories Recent Developments/Updates
9.4.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
9.5 Werfen
9.5.1 Werfen Details
9.5.2 Werfen Major Business
9.5.3 Werfen Donor Transfusion Diagnosis Product and Services
9.5.4 Werfen Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Werfen Recent Developments/Updates
9.5.6 Werfen Competitive Strengths & Weaknesses
9.6 QuidelOrtho Corporation
9.6.1 QuidelOrtho Corporation Details
9.6.2 QuidelOrtho Corporation Major Business
9.6.3 QuidelOrtho Corporation Donor Transfusion Diagnosis Product and Services
9.6.4 QuidelOrtho Corporation Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 QuidelOrtho Corporation Recent Developments/Updates
9.6.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.7 AliveDx Holdings Finance
9.7.1 AliveDx Holdings Finance Details
9.7.2 AliveDx Holdings Finance Major Business
9.7.3 AliveDx Holdings Finance Donor Transfusion Diagnosis Product and Services
9.7.4 AliveDx Holdings Finance Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 AliveDx Holdings Finance Recent Developments/Updates
9.7.6 AliveDx Holdings Finance Competitive Strengths & Weaknesses
9.8 BAG Diagnostics GmbH
9.8.1 BAG Diagnostics GmbH Details
9.8.2 BAG Diagnostics GmbH Major Business
9.8.3 BAG Diagnostics GmbH Donor Transfusion Diagnosis Product and Services
9.8.4 BAG Diagnostics GmbH Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BAG Diagnostics GmbH Recent Developments/Updates
9.8.6 BAG Diagnostics GmbH Competitive Strengths & Weaknesses
9.9 Diasorin
9.9.1 Diasorin Details
9.9.2 Diasorin Major Business
9.9.3 Diasorin Donor Transfusion Diagnosis Product and Services
9.9.4 Diasorin Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Diasorin Recent Developments/Updates
9.9.6 Diasorin Competitive Strengths & Weaknesses
9.10 Prestige Diagnostics
9.10.1 Prestige Diagnostics Details
9.10.2 Prestige Diagnostics Major Business
9.10.3 Prestige Diagnostics Donor Transfusion Diagnosis Product and Services
9.10.4 Prestige Diagnostics Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Prestige Diagnostics Recent Developments/Updates
9.10.6 Prestige Diagnostics Competitive Strengths & Weaknesses
9.11 Atlas Medical GmbH
9.11.1 Atlas Medical GmbH Details
9.11.2 Atlas Medical GmbH Major Business
9.11.3 Atlas Medical GmbH Donor Transfusion Diagnosis Product and Services
9.11.4 Atlas Medical GmbH Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Atlas Medical GmbH Recent Developments/Updates
9.11.6 Atlas Medical GmbH Competitive Strengths & Weaknesses
9.12 Lorne Laboratories
9.12.1 Lorne Laboratories Details
9.12.2 Lorne Laboratories Major Business
9.12.3 Lorne Laboratories Donor Transfusion Diagnosis Product and Services
9.12.4 Lorne Laboratories Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Lorne Laboratories Recent Developments/Updates
9.12.6 Lorne Laboratories Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Donor Transfusion Diagnosis Industry Chain
10.2 Donor Transfusion Diagnosis Upstream Analysis
10.3 Donor Transfusion Diagnosis Midstream Analysis
10.4 Donor Transfusion Diagnosis Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Donor Transfusion Diagnosis Introduction
1.2 World Donor Transfusion Diagnosis Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Donor Transfusion Diagnosis Total Market by Region (by Headquarter Location)
1.3.1 World Donor Transfusion Diagnosis Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.3 China Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.4 Europe Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.5 Japan Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.6 South Korea Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.7 ASEAN Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.3.8 India Based Company Donor Transfusion Diagnosis Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Donor Transfusion Diagnosis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.2 World Donor Transfusion Diagnosis Consumption Value by Region
2.2.1 World Donor Transfusion Diagnosis Consumption Value by Region (2021-2026)
2.2.2 World Donor Transfusion Diagnosis Consumption Value Forecast by Region (2027-2032)
2.3 United States Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.4 China Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.5 Europe Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.6 Japan Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.7 South Korea Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.8 ASEAN Donor Transfusion Diagnosis Consumption Value (2021-2032)
2.9 India Donor Transfusion Diagnosis Consumption Value (2021-2032)
3 WORLD DONOR TRANSFUSION DIAGNOSIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Donor Transfusion Diagnosis Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Donor Transfusion Diagnosis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Donor Transfusion Diagnosis in 2025
3.2.3 Global Concentration Ratios (CR8) for Donor Transfusion Diagnosis in 2025
3.3 Donor Transfusion Diagnosis Company Evaluation Quadrant
3.4 Donor Transfusion Diagnosis Market: Overall Company Footprint Analysis
3.4.1 Donor Transfusion Diagnosis Market: Region Footprint
3.4.2 Donor Transfusion Diagnosis Market: Company Product Type Footprint
3.4.3 Donor Transfusion Diagnosis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Donor Transfusion Diagnosis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Donor Transfusion Diagnosis Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Donor Transfusion Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Donor Transfusion Diagnosis Consumption Value Comparison
4.2.1 United States VS China: Donor Transfusion Diagnosis Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Donor Transfusion Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Donor Transfusion Diagnosis Companies and Market Share, 2021-2026
4.3.1 United States Based Donor Transfusion Diagnosis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Donor Transfusion Diagnosis Revenue, (2021-2026)
4.4 China Based Companies Donor Transfusion Diagnosis Revenue and Market Share, 2021-2026
4.4.1 China Based Donor Transfusion Diagnosis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Donor Transfusion Diagnosis Revenue, (2021-2026)
4.5 Rest of World Based Donor Transfusion Diagnosis Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Donor Transfusion Diagnosis Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Donor Transfusion Diagnosis Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Donor Transfusion Diagnosis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Instruments
5.2.2 Kits and Reagents
5.3 Market Segment by Type
5.3.1 World Donor Transfusion Diagnosis Market Size by Type (2021-2026)
5.3.2 World Donor Transfusion Diagnosis Market Size by Type (2027-2032)
5.3.3 World Donor Transfusion Diagnosis Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TEST TARGET
6.1 World Donor Transfusion Diagnosis Market Size Overview by Test Target: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Test Target
6.2.1 Blood Type Identification
6.2.2 Infectious Disease Screening
6.2.3 Antibody Screening
6.3 Market Segment by Test Target
6.3.1 World Donor Transfusion Diagnosis Market Size by Test Target (2021-2026)
6.3.2 World Donor Transfusion Diagnosis Market Size by Test Target (2027-2032)
6.3.3 World Donor Transfusion Diagnosis Market Size Market Share by Test Target (2027-2032)
7 MARKET ANALYSIS BY EQUIPMENT TYPE
7.1 World Donor Transfusion Diagnosis Market Size Overview by Equipment Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Equipment Type
7.2.1 Automated Blood Testing System
7.2.2 Manual Diagnostic Kit
7.2.3 Integrated Blood Analysis System
7.3 Market Segment by Equipment Type
7.3.1 World Donor Transfusion Diagnosis Market Size by Equipment Type (2021-2026)
7.3.2 World Donor Transfusion Diagnosis Market Size by Equipment Type (2027-2032)
7.3.3 World Donor Transfusion Diagnosis Market Size Market Share by Equipment Type (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Donor Transfusion Diagnosis Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Blood Banks
8.2.2 Blood Donation/Transfusion Centers
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Donor Transfusion Diagnosis Market Size by Application (2021-2026)
8.3.2 World Donor Transfusion Diagnosis Market Size by Application (2027-2032)
8.3.3 World Donor Transfusion Diagnosis Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Grifols
9.1.1 Grifols Details
9.1.2 Grifols Major Business
9.1.3 Grifols Donor Transfusion Diagnosis Product and Services
9.1.4 Grifols Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Grifols Recent Developments/Updates
9.1.6 Grifols Competitive Strengths & Weaknesses
9.2 F. Hoffmann-La Roche
9.2.1 F. Hoffmann-La Roche Details
9.2.2 F. Hoffmann-La Roche Major Business
9.2.3 F. Hoffmann-La Roche Donor Transfusion Diagnosis Product and Services
9.2.4 F. Hoffmann-La Roche Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 F. Hoffmann-La Roche Recent Developments/Updates
9.2.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
9.3 Abbott
9.3.1 Abbott Details
9.3.2 Abbott Major Business
9.3.3 Abbott Donor Transfusion Diagnosis Product and Services
9.3.4 Abbott Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Abbott Recent Developments/Updates
9.3.6 Abbott Competitive Strengths & Weaknesses
9.4 Bio-Rad Laboratories
9.4.1 Bio-Rad Laboratories Details
9.4.2 Bio-Rad Laboratories Major Business
9.4.3 Bio-Rad Laboratories Donor Transfusion Diagnosis Product and Services
9.4.4 Bio-Rad Laboratories Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Bio-Rad Laboratories Recent Developments/Updates
9.4.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
9.5 Werfen
9.5.1 Werfen Details
9.5.2 Werfen Major Business
9.5.3 Werfen Donor Transfusion Diagnosis Product and Services
9.5.4 Werfen Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Werfen Recent Developments/Updates
9.5.6 Werfen Competitive Strengths & Weaknesses
9.6 QuidelOrtho Corporation
9.6.1 QuidelOrtho Corporation Details
9.6.2 QuidelOrtho Corporation Major Business
9.6.3 QuidelOrtho Corporation Donor Transfusion Diagnosis Product and Services
9.6.4 QuidelOrtho Corporation Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 QuidelOrtho Corporation Recent Developments/Updates
9.6.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
9.7 AliveDx Holdings Finance
9.7.1 AliveDx Holdings Finance Details
9.7.2 AliveDx Holdings Finance Major Business
9.7.3 AliveDx Holdings Finance Donor Transfusion Diagnosis Product and Services
9.7.4 AliveDx Holdings Finance Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 AliveDx Holdings Finance Recent Developments/Updates
9.7.6 AliveDx Holdings Finance Competitive Strengths & Weaknesses
9.8 BAG Diagnostics GmbH
9.8.1 BAG Diagnostics GmbH Details
9.8.2 BAG Diagnostics GmbH Major Business
9.8.3 BAG Diagnostics GmbH Donor Transfusion Diagnosis Product and Services
9.8.4 BAG Diagnostics GmbH Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BAG Diagnostics GmbH Recent Developments/Updates
9.8.6 BAG Diagnostics GmbH Competitive Strengths & Weaknesses
9.9 Diasorin
9.9.1 Diasorin Details
9.9.2 Diasorin Major Business
9.9.3 Diasorin Donor Transfusion Diagnosis Product and Services
9.9.4 Diasorin Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Diasorin Recent Developments/Updates
9.9.6 Diasorin Competitive Strengths & Weaknesses
9.10 Prestige Diagnostics
9.10.1 Prestige Diagnostics Details
9.10.2 Prestige Diagnostics Major Business
9.10.3 Prestige Diagnostics Donor Transfusion Diagnosis Product and Services
9.10.4 Prestige Diagnostics Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Prestige Diagnostics Recent Developments/Updates
9.10.6 Prestige Diagnostics Competitive Strengths & Weaknesses
9.11 Atlas Medical GmbH
9.11.1 Atlas Medical GmbH Details
9.11.2 Atlas Medical GmbH Major Business
9.11.3 Atlas Medical GmbH Donor Transfusion Diagnosis Product and Services
9.11.4 Atlas Medical GmbH Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Atlas Medical GmbH Recent Developments/Updates
9.11.6 Atlas Medical GmbH Competitive Strengths & Weaknesses
9.12 Lorne Laboratories
9.12.1 Lorne Laboratories Details
9.12.2 Lorne Laboratories Major Business
9.12.3 Lorne Laboratories Donor Transfusion Diagnosis Product and Services
9.12.4 Lorne Laboratories Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Lorne Laboratories Recent Developments/Updates
9.12.6 Lorne Laboratories Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Donor Transfusion Diagnosis Industry Chain
10.2 Donor Transfusion Diagnosis Upstream Analysis
10.3 Donor Transfusion Diagnosis Midstream Analysis
10.4 Donor Transfusion Diagnosis Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Donor Transfusion Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Donor Transfusion Diagnosis Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Donor Transfusion Diagnosis Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Donor Transfusion Diagnosis Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Donor Transfusion Diagnosis Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Donor Transfusion Diagnosis Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Donor Transfusion Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Donor Transfusion Diagnosis Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Donor Transfusion Diagnosis Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Donor Transfusion Diagnosis Players in 2025
Table 12. World Donor Transfusion Diagnosis Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Donor Transfusion Diagnosis Company Evaluation Quadrant
Table 14. Head Office of Key Donor Transfusion Diagnosis Players
Table 15. Donor Transfusion Diagnosis Market: Company Product Type Footprint
Table 16. Donor Transfusion Diagnosis Market: Company Product Application Footprint
Table 17. Donor Transfusion Diagnosis Mergers & Acquisitions Activity
Table 18. United States VS China Donor Transfusion Diagnosis Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Donor Transfusion Diagnosis Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Donor Transfusion Diagnosis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Donor Transfusion Diagnosis Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Donor Transfusion Diagnosis Revenue Market Share (2021-2026)
Table 23. China Based Donor Transfusion Diagnosis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Donor Transfusion Diagnosis Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Donor Transfusion Diagnosis Revenue Market Share (2021-2026)
Table 26. Rest of World Based Donor Transfusion Diagnosis Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Donor Transfusion Diagnosis Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Donor Transfusion Diagnosis Revenue Market Share (2021-2026)
Table 29. World Donor Transfusion Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Donor Transfusion Diagnosis Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Donor Transfusion Diagnosis Market Size by Type (2027-2032) & (USD Million)
Table 32. World Donor Transfusion Diagnosis Market Size by Test Target, (USD Million), 2021 & 2025 & 2032
Table 33. World Donor Transfusion Diagnosis Market Size Value by Test Target (2021-2026) & (USD Million)
Table 34. World Donor Transfusion Diagnosis Market Size by Test Target (2027-2032) & (USD Million)
Table 35. World Donor Transfusion Diagnosis Market Size by Equipment Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Donor Transfusion Diagnosis Market Size Value by Equipment Type (2021-2026) & (USD Million)
Table 37. World Donor Transfusion Diagnosis Market Size by Equipment Type (2027-2032) & (USD Million)
Table 38. World Donor Transfusion Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Donor Transfusion Diagnosis Market Size by Application (2021-2026) & (USD Million)
Table 40. World Donor Transfusion Diagnosis Market Size by Application (2027-2032) & (USD Million)
Table 41. Grifols Basic Information, Manufacturing Base and Competitors
Table 42. Grifols Major Business
Table 43. Grifols Donor Transfusion Diagnosis Product and Services
Table 44. Grifols Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Grifols Recent Developments/Updates
Table 46. Grifols Competitive Strengths & Weaknesses
Table 47. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 48. F. Hoffmann-La Roche Major Business
Table 49. F. Hoffmann-La Roche Donor Transfusion Diagnosis Product and Services
Table 50. F. Hoffmann-La Roche Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. F. Hoffmann-La Roche Recent Developments/Updates
Table 52. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 53. Abbott Basic Information, Manufacturing Base and Competitors
Table 54. Abbott Major Business
Table 55. Abbott Donor Transfusion Diagnosis Product and Services
Table 56. Abbott Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Abbott Recent Developments/Updates
Table 58. Abbott Competitive Strengths & Weaknesses
Table 59. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Bio-Rad Laboratories Major Business
Table 61. Bio-Rad Laboratories Donor Transfusion Diagnosis Product and Services
Table 62. Bio-Rad Laboratories Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Bio-Rad Laboratories Recent Developments/Updates
Table 64. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 65. Werfen Basic Information, Manufacturing Base and Competitors
Table 66. Werfen Major Business
Table 67. Werfen Donor Transfusion Diagnosis Product and Services
Table 68. Werfen Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Werfen Recent Developments/Updates
Table 70. Werfen Competitive Strengths & Weaknesses
Table 71. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 72. QuidelOrtho Corporation Major Business
Table 73. QuidelOrtho Corporation Donor Transfusion Diagnosis Product and Services
Table 74. QuidelOrtho Corporation Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. QuidelOrtho Corporation Recent Developments/Updates
Table 76. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 77. AliveDx Holdings Finance Basic Information, Manufacturing Base and Competitors
Table 78. AliveDx Holdings Finance Major Business
Table 79. AliveDx Holdings Finance Donor Transfusion Diagnosis Product and Services
Table 80. AliveDx Holdings Finance Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. AliveDx Holdings Finance Recent Developments/Updates
Table 82. AliveDx Holdings Finance Competitive Strengths & Weaknesses
Table 83. BAG Diagnostics GmbH Basic Information, Manufacturing Base and Competitors
Table 84. BAG Diagnostics GmbH Major Business
Table 85. BAG Diagnostics GmbH Donor Transfusion Diagnosis Product and Services
Table 86. BAG Diagnostics GmbH Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. BAG Diagnostics GmbH Recent Developments/Updates
Table 88. BAG Diagnostics GmbH Competitive Strengths & Weaknesses
Table 89. Diasorin Basic Information, Manufacturing Base and Competitors
Table 90. Diasorin Major Business
Table 91. Diasorin Donor Transfusion Diagnosis Product and Services
Table 92. Diasorin Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Diasorin Recent Developments/Updates
Table 94. Diasorin Competitive Strengths & Weaknesses
Table 95. Prestige Diagnostics Basic Information, Manufacturing Base and Competitors
Table 96. Prestige Diagnostics Major Business
Table 97. Prestige Diagnostics Donor Transfusion Diagnosis Product and Services
Table 98. Prestige Diagnostics Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Prestige Diagnostics Recent Developments/Updates
Table 100. Prestige Diagnostics Competitive Strengths & Weaknesses
Table 101. Atlas Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 102. Atlas Medical GmbH Major Business
Table 103. Atlas Medical GmbH Donor Transfusion Diagnosis Product and Services
Table 104. Atlas Medical GmbH Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Atlas Medical GmbH Recent Developments/Updates
Table 106. Atlas Medical GmbH Competitive Strengths & Weaknesses
Table 107. Lorne Laboratories Basic Information, Manufacturing Base and Competitors
Table 108. Lorne Laboratories Major Business
Table 109. Lorne Laboratories Donor Transfusion Diagnosis Product and Services
Table 110. Lorne Laboratories Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Lorne Laboratories Recent Developments/Updates
Table 112. Lorne Laboratories Competitive Strengths & Weaknesses
Table 113. Global Key Players of Donor Transfusion Diagnosis Upstream (Raw Materials)
Table 114. Global Donor Transfusion Diagnosis Typical Customers
Table 1. World Donor Transfusion Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Donor Transfusion Diagnosis Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Donor Transfusion Diagnosis Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Donor Transfusion Diagnosis Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Donor Transfusion Diagnosis Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Donor Transfusion Diagnosis Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Donor Transfusion Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Donor Transfusion Diagnosis Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Donor Transfusion Diagnosis Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Donor Transfusion Diagnosis Players in 2025
Table 12. World Donor Transfusion Diagnosis Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Donor Transfusion Diagnosis Company Evaluation Quadrant
Table 14. Head Office of Key Donor Transfusion Diagnosis Players
Table 15. Donor Transfusion Diagnosis Market: Company Product Type Footprint
Table 16. Donor Transfusion Diagnosis Market: Company Product Application Footprint
Table 17. Donor Transfusion Diagnosis Mergers & Acquisitions Activity
Table 18. United States VS China Donor Transfusion Diagnosis Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Donor Transfusion Diagnosis Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Donor Transfusion Diagnosis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Donor Transfusion Diagnosis Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Donor Transfusion Diagnosis Revenue Market Share (2021-2026)
Table 23. China Based Donor Transfusion Diagnosis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Donor Transfusion Diagnosis Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Donor Transfusion Diagnosis Revenue Market Share (2021-2026)
Table 26. Rest of World Based Donor Transfusion Diagnosis Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Donor Transfusion Diagnosis Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Donor Transfusion Diagnosis Revenue Market Share (2021-2026)
Table 29. World Donor Transfusion Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Donor Transfusion Diagnosis Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Donor Transfusion Diagnosis Market Size by Type (2027-2032) & (USD Million)
Table 32. World Donor Transfusion Diagnosis Market Size by Test Target, (USD Million), 2021 & 2025 & 2032
Table 33. World Donor Transfusion Diagnosis Market Size Value by Test Target (2021-2026) & (USD Million)
Table 34. World Donor Transfusion Diagnosis Market Size by Test Target (2027-2032) & (USD Million)
Table 35. World Donor Transfusion Diagnosis Market Size by Equipment Type, (USD Million), 2021 & 2025 & 2032
Table 36. World Donor Transfusion Diagnosis Market Size Value by Equipment Type (2021-2026) & (USD Million)
Table 37. World Donor Transfusion Diagnosis Market Size by Equipment Type (2027-2032) & (USD Million)
Table 38. World Donor Transfusion Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Donor Transfusion Diagnosis Market Size by Application (2021-2026) & (USD Million)
Table 40. World Donor Transfusion Diagnosis Market Size by Application (2027-2032) & (USD Million)
Table 41. Grifols Basic Information, Manufacturing Base and Competitors
Table 42. Grifols Major Business
Table 43. Grifols Donor Transfusion Diagnosis Product and Services
Table 44. Grifols Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Grifols Recent Developments/Updates
Table 46. Grifols Competitive Strengths & Weaknesses
Table 47. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 48. F. Hoffmann-La Roche Major Business
Table 49. F. Hoffmann-La Roche Donor Transfusion Diagnosis Product and Services
Table 50. F. Hoffmann-La Roche Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. F. Hoffmann-La Roche Recent Developments/Updates
Table 52. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 53. Abbott Basic Information, Manufacturing Base and Competitors
Table 54. Abbott Major Business
Table 55. Abbott Donor Transfusion Diagnosis Product and Services
Table 56. Abbott Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Abbott Recent Developments/Updates
Table 58. Abbott Competitive Strengths & Weaknesses
Table 59. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Bio-Rad Laboratories Major Business
Table 61. Bio-Rad Laboratories Donor Transfusion Diagnosis Product and Services
Table 62. Bio-Rad Laboratories Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Bio-Rad Laboratories Recent Developments/Updates
Table 64. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 65. Werfen Basic Information, Manufacturing Base and Competitors
Table 66. Werfen Major Business
Table 67. Werfen Donor Transfusion Diagnosis Product and Services
Table 68. Werfen Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Werfen Recent Developments/Updates
Table 70. Werfen Competitive Strengths & Weaknesses
Table 71. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 72. QuidelOrtho Corporation Major Business
Table 73. QuidelOrtho Corporation Donor Transfusion Diagnosis Product and Services
Table 74. QuidelOrtho Corporation Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. QuidelOrtho Corporation Recent Developments/Updates
Table 76. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 77. AliveDx Holdings Finance Basic Information, Manufacturing Base and Competitors
Table 78. AliveDx Holdings Finance Major Business
Table 79. AliveDx Holdings Finance Donor Transfusion Diagnosis Product and Services
Table 80. AliveDx Holdings Finance Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. AliveDx Holdings Finance Recent Developments/Updates
Table 82. AliveDx Holdings Finance Competitive Strengths & Weaknesses
Table 83. BAG Diagnostics GmbH Basic Information, Manufacturing Base and Competitors
Table 84. BAG Diagnostics GmbH Major Business
Table 85. BAG Diagnostics GmbH Donor Transfusion Diagnosis Product and Services
Table 86. BAG Diagnostics GmbH Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. BAG Diagnostics GmbH Recent Developments/Updates
Table 88. BAG Diagnostics GmbH Competitive Strengths & Weaknesses
Table 89. Diasorin Basic Information, Manufacturing Base and Competitors
Table 90. Diasorin Major Business
Table 91. Diasorin Donor Transfusion Diagnosis Product and Services
Table 92. Diasorin Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Diasorin Recent Developments/Updates
Table 94. Diasorin Competitive Strengths & Weaknesses
Table 95. Prestige Diagnostics Basic Information, Manufacturing Base and Competitors
Table 96. Prestige Diagnostics Major Business
Table 97. Prestige Diagnostics Donor Transfusion Diagnosis Product and Services
Table 98. Prestige Diagnostics Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Prestige Diagnostics Recent Developments/Updates
Table 100. Prestige Diagnostics Competitive Strengths & Weaknesses
Table 101. Atlas Medical GmbH Basic Information, Manufacturing Base and Competitors
Table 102. Atlas Medical GmbH Major Business
Table 103. Atlas Medical GmbH Donor Transfusion Diagnosis Product and Services
Table 104. Atlas Medical GmbH Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Atlas Medical GmbH Recent Developments/Updates
Table 106. Atlas Medical GmbH Competitive Strengths & Weaknesses
Table 107. Lorne Laboratories Basic Information, Manufacturing Base and Competitors
Table 108. Lorne Laboratories Major Business
Table 109. Lorne Laboratories Donor Transfusion Diagnosis Product and Services
Table 110. Lorne Laboratories Donor Transfusion Diagnosis Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Lorne Laboratories Recent Developments/Updates
Table 112. Lorne Laboratories Competitive Strengths & Weaknesses
Table 113. Global Key Players of Donor Transfusion Diagnosis Upstream (Raw Materials)
Table 114. Global Donor Transfusion Diagnosis Typical Customers
LIST OF FIGURES
Figure 1. Donor Transfusion Diagnosis Picture
Figure 2. World Donor Transfusion Diagnosis Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Donor Transfusion Diagnosis Total Revenue (2021-2032) & (USD Million)
Figure 4. World Donor Transfusion Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Donor Transfusion Diagnosis Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 13. Donor Transfusion Diagnosis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 16. World Donor Transfusion Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 18. China Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 23. India Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Donor Transfusion Diagnosis by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Donor Transfusion Diagnosis Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Donor Transfusion Diagnosis Markets in 2025
Figure 27. United States VS China: Donor Transfusion Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Donor Transfusion Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Donor Transfusion Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Donor Transfusion Diagnosis Market Size Market Share by Type in 2025
Figure 31. Instruments
Figure 32. Kits and Reagents
Figure 33. World Donor Transfusion Diagnosis Market Size Market Share by Type (2021-2032)
Figure 34. World Donor Transfusion Diagnosis Market Size by Test Target, (USD Million), 2021 & 2025 & 2032
Figure 35. World Donor Transfusion Diagnosis Market Size Market Share by Test Target in 2025
Figure 36. Blood Type Identification
Figure 37. Infectious Disease Screening
Figure 38. Antibody Screening
Figure 39. World Donor Transfusion Diagnosis Market Size Market Share by Test Target (2021-2032)
Figure 40. World Donor Transfusion Diagnosis Market Size by Equipment Type, (USD Million), 2021 & 2025 & 2032
Figure 41. World Donor Transfusion Diagnosis Market Size Market Share by Equipment Type in 2025
Figure 42. Automated Blood Testing System
Figure 43. Manual Diagnostic Kit
Figure 44. Integrated Blood Analysis System
Figure 45. World Donor Transfusion Diagnosis Market Size Market Share by Equipment Type (2021-2032)
Figure 46. World Donor Transfusion Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Donor Transfusion Diagnosis Market Size Market Share by Application in 2025
Figure 48. Blood Banks
Figure 49. Blood Donation/Transfusion Centers
Figure 50. Others
Figure 51. World Donor Transfusion Diagnosis Market Size Market Share by Application (2021-2032)
Figure 52. Donor Transfusion Diagnosis Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Donor Transfusion Diagnosis Picture
Figure 2. World Donor Transfusion Diagnosis Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Donor Transfusion Diagnosis Total Revenue (2021-2032) & (USD Million)
Figure 4. World Donor Transfusion Diagnosis Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Donor Transfusion Diagnosis Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Donor Transfusion Diagnosis Revenue (2021-2032) & (USD Million)
Figure 13. Donor Transfusion Diagnosis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 16. World Donor Transfusion Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 18. China Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 23. India Donor Transfusion Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Donor Transfusion Diagnosis by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Donor Transfusion Diagnosis Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Donor Transfusion Diagnosis Markets in 2025
Figure 27. United States VS China: Donor Transfusion Diagnosis Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Donor Transfusion Diagnosis Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Donor Transfusion Diagnosis Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Donor Transfusion Diagnosis Market Size Market Share by Type in 2025
Figure 31. Instruments
Figure 32. Kits and Reagents
Figure 33. World Donor Transfusion Diagnosis Market Size Market Share by Type (2021-2032)
Figure 34. World Donor Transfusion Diagnosis Market Size by Test Target, (USD Million), 2021 & 2025 & 2032
Figure 35. World Donor Transfusion Diagnosis Market Size Market Share by Test Target in 2025
Figure 36. Blood Type Identification
Figure 37. Infectious Disease Screening
Figure 38. Antibody Screening
Figure 39. World Donor Transfusion Diagnosis Market Size Market Share by Test Target (2021-2032)
Figure 40. World Donor Transfusion Diagnosis Market Size by Equipment Type, (USD Million), 2021 & 2025 & 2032
Figure 41. World Donor Transfusion Diagnosis Market Size Market Share by Equipment Type in 2025
Figure 42. Automated Blood Testing System
Figure 43. Manual Diagnostic Kit
Figure 44. Integrated Blood Analysis System
Figure 45. World Donor Transfusion Diagnosis Market Size Market Share by Equipment Type (2021-2032)
Figure 46. World Donor Transfusion Diagnosis Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Donor Transfusion Diagnosis Market Size Market Share by Application in 2025
Figure 48. Blood Banks
Figure 49. Blood Donation/Transfusion Centers
Figure 50. Others
Figure 51. World Donor Transfusion Diagnosis Market Size Market Share by Application (2021-2032)
Figure 52. Donor Transfusion Diagnosis Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
